Dermatologist Warns About Sun Damage On 'Don't Fry Day'
Chief of Mount Sinai’s Division of Dermatologic & Cosmetic Surgery Dr. Ellen Marmur knows first-hand how dangerous the sun can be. “I had my second skin cancer scare recently, which is why I have a nice scar on my face,” she said. With one American dying every hour from skin cancer, Dr. Marmur tries to educate her patients at The Mount Sinai Medical Center about the dangers of too much sun. She said her cancers started off as something that looked like a small, hard, pink pimple. She blames not wearing sunscreen as a teenager. “I'm happy to show my patients my scars. It's the best thing I can do,” Dr. Marmur said.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.
"Experimental Oral Drug May Be Effective In Treating Metastatic Basal Cell Carcinoma"
Oct 01, 2011 View All Press Releases